Potential broad-spectrum antitumor properties of clofarabine
Release time：
Sep 26,2022
Potential broad-spectrum anti-tumor properties of clofarabine: There are more than 20 clinical indications in the United States, and it is a very potential broad-spectrum anti-cancer drug.
Potential broad-spectrum anti-tumor properties of clofarabine: There are more than 20 clinical indications in the United States, and it is a very potential broad-spectrum anti-cancer drug.
The current clinical indications are: breast cancer, lung cancer, colorectal cancer, prostate cancer, kidney cancer, cervical cancer, pancreatic cancer, skin cancer, bladder cancer, non-small cell lung cancer, oral cancer, nasopharyngeal cancer, laryngeal cancer, Most of the phase I clinical studies of maxillary sinus cancer, esophageal cancer, uterine tumor, melanoma, and leiomyosarcoma have been completed. Acute myeloid leukemia, chronic lymphoma, and non-Hodgkin's lymphoma are in Phase II clinical research, and research on inhibiting transplant rejection is in Phase I clinical research. Therefore, while being used for the treatment of acute leukemia, its potential indications include many solid tumors and some immune diseases.
Related news
Follow WeChat
Anhui Union Pharmaceuticals Technology Co., Ltd.
Service line:
+86-21-54285906
E-mail：2880705932@qq.com
Add：4th Floor, Building B3, Creative Industry Park, Hefei, Anhui P. R. China.
Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.